ICLR

ICON Public Limited Company

There isn't enough reported data to score ICLR yet.

ICLR Fundamentals

MetricStatus
Healthy
Stable
Healthy
Stable

ICLR's revenue and cash flow are currently healthy, and its profitability and balance sheet are stable.

ICLR PE Valuation

ICLR has no meaningful PE right now: it lost money over the past year.

ICLR Forward outlook

MetricOutlook
--
Stable
Stable
Stable
Limited
High

Analysts expect ICLR's earnings, revenue and profitability to hold roughly steady.

ICLR Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $200.51 on Nov 12.

There is not enough scenario data to assess ICLR's risk to reward.

ICLR Earnings Per Share

Q4 2023: $7.40Q1 2024: $8.24Q2 2024: $8.60Q3 2024: $8.99Q4 2024: $9.53Q1 2025: $9.18Q2 2025: $9.72Q3 2025: $7.39Q4 2025: $2.90Forward: $11.26
Q4 2023: $7.40Q1 2024: $8.24Q2 2024: $8.60Q3 2024: $8.99Q4 2024: $9.53Q1 2025: $9.18Q2 2025: $9.72Q3 2025: $7.39Q4 2025: $2.90Forward: $11.26
QuarterTTM EPSYoY
Forward$11.26+288%
Q4 2025$2.90-70%
Q3 2025$7.39-18%
Q2 2025$9.72+13%
Q1 2025$9.18+11%
Q4 2024$9.53+29%
Q3 2024$8.99+45%
Q2 2024$8.60+39%
Q1 2024$8.24+33%

ICLR earned $2.90 per share over the past year, down 70% from the year before.

ICLR Quarterly Revenue

Q4 2023: $2.1BQ1 2024: $2.1BQ2 2024: $2.1BQ3 2024: $2BQ4 2024: $2BQ1 2025: $2BQ2 2025: $2BQ3 2025: $2BQ4 2025: $8.3BQ1 2026: $2BQ2 2026: $2.1BQ3 2026: $2B
Q4 2023: $2.1BQ1 2024: $2.1BQ2 2024: $2.1BQ3 2024: $2BQ4 2024: $2BQ1 2025: $2BQ2 2025: $2BQ3 2025: $2BQ4 2025: $8.3BQ1 2026: $2BQ2 2026: $2.1BQ3 2026: $2B
QuarterRevenueYoY
Q3 2026$2B-0.9%
Q2 2026$2.1B+2.3%
Q1 2026$2B+1.6%
Q4 2025$8.3B+304%
Q3 2025$2B+0.6%
Q2 2025$2B-4.8%
Q1 2025$2B-4.3%
Q4 2024$2B-1.2%

ICLR's revenue has picked up after three years of holding roughly level: $2B last quarter, about level with the same quarter a year ago.

ICLR Free Cash Flow

Q4 2023: $387MQ1 2024: $300MQ2 2024: $182MQ3 2024: $359MQ4 2024: $277MQ1 2025: $239MQ2 2025: $114MQ3 2025: $334MQ4 2025: $862MQ1 2026: $136MQ2 2026: $239MQ3 2026: $307M
Q4 2023: $387MQ1 2024: $300MQ2 2024: $182MQ3 2024: $359MQ4 2024: $277MQ1 2025: $239MQ2 2025: $114MQ3 2025: $334MQ4 2025: $862MQ1 2026: $136MQ2 2026: $239MQ3 2026: $307M
QuarterFree cash flowYoY
Q3 2026$307.1M-8%
Q2 2026$238.8M+110%
Q1 2026$136.2M-43%
Q4 2025$862M+211%
Q3 2025$333.9M-7.1%
Q2 2025$113.9M-38%
Q1 2025$239.3M-20%
Q4 2024$277M-28%

ICLR generated $1.5B in free cash flow over the past year, up 60% from the year before.

ICLR Total Shares

Q4 2023: 83MQ1 2024: 83MQ2 2024: 83MQ3 2024: 83MQ4 2024: 83MQ1 2025: 81MQ2 2025: 80MQ3 2025: 78MQ4 2025: 79MQ1 2026: 77MQ2 2026: 77MQ3 2026: 77M
Q4 2023: 83MQ1 2024: 83MQ2 2024: 83MQ3 2024: 83MQ4 2024: 83MQ1 2025: 81MQ2 2025: 80MQ3 2025: 78MQ4 2025: 79MQ1 2026: 77MQ2 2026: 77MQ3 2026: 77M
PeriodChange %Net change
Quarterly0%+32.7K shares
1 year-0.9%-678K shares
3 years-6.7%-5.6M shares
5 years-4.2%-3.4M shares
Available history+42%+23.1M shares

ICLR has 77M diluted shares, down 0.9% from a year ago, with $1.1B in buybacks over the past year.

ICLR Net Leverage

Q4 2023: 2.1xQ1 2024: 1.9xQ2 2024: 1.8xQ3 2024: 1.7xQ4 2024: 1.8xQ1 2025: 2.0xQ2 2025: 2.2xQ3 2025: 2.0xQ4 2025: 2.7x
Q4 2023: 2.1xQ1 2024: 1.9xQ2 2024: 1.8xQ3 2024: 1.7xQ4 2024: 1.8xQ1 2025: 2.0xQ2 2025: 2.2xQ3 2025: 2.0xQ4 2025: 2.7x
QuarterNet LeverageStatus
Q4 20252.7xModerate
Q3 20252.0xModerate
Q2 20252.2xModerate
Q1 20252.0xHealthy
Q4 20241.8xHealthy
Q3 20241.7xHealthy
Q2 20241.8xHealthy
Q1 20241.9xHealthy

ICLR's net debt is about 2.7 years of its operating earnings (EBITDA), up from 1.8 years a year ago.

ICLR Weekly Momentum

MetricValueStatus
RSI65.0Neutral
Stochastic79.3Neutral

ICLR's weekly RSI is 65 (neutral) and its Stochastic is 79 (neutral).

ICLR PE vs Healthcare Sector

MetricICLRSector medianRelative
PEN/A26x—

ICLR has no meaningful PE right now: it lost money over the past year.

ICLR Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$183.89.1% above
20 week MA$173.915% above
50 week MA$152.931% above
100 week MA$161.824% above
200 week MA$213.56.1% below

ICLR has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 6.1% below its 200-week average.

ICLR Yearly ROI

YearStart priceEnd priceROI
2020$171.9$192.5+12%
2021$192.5$307.9+60%
2022$307.9$194.9-37%
2023$194.9$283.1+45%
2024$283.1$212.3-25%
2025$212.3$182.8-14%
2026 YTD$182.8$200.5+9.7%

ICLR has finished lower in three of the last six years. It's up 9.7% so far in 2026.

Give your agent the market.

Get API key